Inventor · disambiguated record
Christopher Winter
Also filed as: WINTER CHRISTOPHER · WINTER CHRISTOPHER G
6 granted patents·12 pending applications·11 citations·filing 2004–2024
75Inventor score
Top patents by PatentIndex Score
18 records- 0193US11242384B2Anti-TGF-beta antibodies and their useSANOFI SA·Filed 2020·Granted Feb 8, 2022·4 cites·14 claims
- 0286US10766955B2Anti-TGF-β antibodies and their useSANOFI SA·Filed 2018·Granted Sep 8, 2020·4 cites·33 claims
- 0381US2025026821A1Anti-tgf-beta antibodies and their useSANOFI SA·Filed 2024·Application pending·0 cites
- 0476US8852590B2Compositions and methods for treating cancerSATHYANARAYANAN SRIRAM·Filed 2010·Granted Oct 7, 2014·3 cites·1 claims
- 0575US12049496B2Anti-TGF-beta antibodies and their useSANOFI SA·Filed 2021·Granted Jul 30, 2024·0 cites·10 claims
- 0657US2008050313A1Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of UseEXELIXIS INC·Filed 2004·Application pending·0 cites
- 0756US2011166028A1Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancersBERGSTROM DONALD·Filed 2008·Application pending·0 cites
- 0848US2013178391A1Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancersRosetta Inpharmaceutics LLC·Filed 2013·Application pending·0 cites
- 0946US2007128606A1Prkcs as modifiers of the beta catenin pathway and methods of useEXELIXIS INC·Filed 2004·Application pending·0 cites
- 1041US2010112566A1VIPR1S as Modifiers of the E2F/RB Pathway and Methods of UseEDGAR KYLE A·Filed 2007·Application pending·0 cites
- 1140US2006246459A1Ups as modifiers of the beta catenin pathway and methods of useEXELIXIS INC·Filed 2004·Application pending·0 cites
- 1239US9110082B2Methods for the identification and treatment of patients sensitive to anti IGF-1R inhibition therapySATHYANARAYANAN SRIRAM·Filed 2010·Granted Aug 18, 2015·0 cites·12 claims
- 1339US8632962B2PLKS as modifiers of the beta catenin pathway and methods of useFRANCIS-LANG HELEN·Filed 2004·Granted Jan 21, 2014·0 cites·14 claims
- 1439US2013287763A1Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitorSATHYANARAYANAN SRIRAM·Filed 2011·Application pending·0 cites
- 1539US2007128666A1Ttbks as modifiers of the beta catenin pathway and methods of useFRANCIS-LANG HELEN·Filed 2004·Application pending·0 cites
- 1636US2019192522A1Inhibitors of the fibroblast growth factor receptor 4 in combination with cyclin-dependent kinase inhibitorsBLUEPRINT MEDICINES CORP·Filed 2017·Application pending·0 cites
- 1733US2007020628A1Tkts as mondifiers of the beta-catenin pathway and methods of useFRANCIS-LANG HELEN·Filed 2004·Application pending·0 cites
- 1828US2012058112A1AntibodiesSATHYANARAYANAN SRIRAM·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →